BioSpace News Archive

Evergreen Organix (EGO Brands) line of award-winning edibles are coming to Washington and Oregon to be manufactured and distributed by Honu of Washington.

MemorialCare only health system, hospitals, medical group in Large Companies Category

Duo will Begin Testing AWS-Hosted Product, Addison Care

North American Cannabis Holdings, Inc. (USOTC: USMJ) (“USMJ”) today released a letter from its CEO and Chairman discussing the potential for the overall cannabis industry to be realized from the 2018 Farm Act that includes, as drafted, the legalization of hemp farming.

Bio-Thera Solutions, a clinical-stage pharmaceutical company, today announced that patient dosing has begun in a Phase I clinical study of BAT4306F in relapsed/refractory CD20-positive B-cell non-Hodgkin’s lymphoma patients.

Biotheranostics, Inc. announced the presentation of new data at the San Antonio Breast Cancer Symposium evaluating the impact of the Breast Cancer Index (BCI) in early stage hormone receptor positive (HR+) breast cancer patients classified as intermediate risk for distant recurrence by previous genomic testing.

Biotech Showcase™, one of the largest biotech investor conferences in the world, today revealed the results of a pre-conference survey of life science executives and investors regarding the 2019 biotech landscape

Virtual Caregiving is set to enter both the healthcare industry and patient home settings. In January 2019, G60 Trauma (G60Trauma.org) will begin testing Addison Care, the world’s first, comprehensive virtual caregiving system to provide real time, 24/7 patient monitoring and care.

Eisai announced today that the first investigational drug candidate from their drug discovery collaboration with University College London (UCL) is to enter Phase I clinical trials for Alzheimer’s disease (AD) in early 2019.

Pulse Biosciences, Inc. today announced the completion of its rights offering, which expired at 5:00 p.m. Eastern Time on December 6, 2018 (the “Expiration Date”).